Augmented debridement for implant related chronic osteomyelitis with an absorbable, gentamycin loaded calcium sulfate/hydroxyapatite biocomposite
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Journal of Orthopaedics
- Vol. 17, 173-179
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Augmentation of tibial plateau fractures with an injectable bone substitute: CERAMENT™. Three year follow-up from a prospective studyBMC Musculoskeletal Disorders, 2015
- The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitisThe Bone & Joint Journal, 2014
- Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureusNature Reviews Microbiology, 2013
- The composite of hydroxyapatite and calcium sulphate: a review of preclinical evaluation and clinical applicationsExpert Review of Medical Devices, 2013
- Local Antibiotic Therapy in OsteomyelitisSeminars in Plastic Surgery, 2009
- Adult osteomyelitis: debridement versus debridement plus Osteoset T pellets.2007
- Treatment of Chronic InfectionJournal of the American Academy of Orthopaedic Surgeons, 2006
- Biodegradation and biocompatability of a calcium sulphate-hydroxyapatite bone substitute.2004
- The Classic: A Clinical Staging System for Adult OsteomyelitisClinical Orthopaedics and Related Research, 2003
- Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantationBiomaterials, 2003